It had posted net profit of Rs 22.98 crore in the July- September quarter of the previous fiscal, 2012-13.
Total income from operations fell by 21% to Rs 365.45 crore in Q2, 2013-14, as against Rs 461.64 crore in the year-ago period, Omaxe said in a filing to the BSE.
Also Read
Recently, Omaxe announced issue of 10 bonus shares to public shareholders for every 39 shares held by them in order to meet market regulator Sebi's norm on minimum 25% public shareholding.
Promoters had 89.14% stake in Omaxe as on March 31. After four-round of Offer For Sale (OFS), Omaxe is still required to increase public shareholding by about 4%.
Omaxe scrip closed at 119.65, down 0.50%, on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)